AAAAAA

   
Results: 1-21 |
Results: 21
CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY
Authors: FURLONG T STORB R ANASETTI C APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN KM WITHERSPOON R NASH RA
Citation: T. Furlong et al., CONVERSION TO FK506 FOR CYCLOSPORINE (CSP)-RESISTANT ACUTE GVHD OR CSP-ASSOCIATED TOXICITY, Blood, 90(10), 1997, pp. 458-458
MYCOPHENOLATE MOFETIL (MMF) AS SALVAGE TREATMENT FOR GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - SAFETY ANALYSIS
Authors: NASH RA FURLONG T STORB R ANASETTI C APPELBAUM FR DEEG HJ DONEY K MARTIN P WITHERSPOON R SULLIVAN KM
Citation: Ra. Nash et al., MYCOPHENOLATE MOFETIL (MMF) AS SALVAGE TREATMENT FOR GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - SAFETY ANALYSIS, Blood, 90(10), 1997, pp. 459-459
COACHING AS A COLLABORATION
Authors: WITHERSPOON R WHITE RP HUTCHESON PG
Citation: R. Witherspoon et al., COACHING AS A COLLABORATION, Training & development, 50(3), 1996, pp. 14-16
RESULTS OF 4 REGIMES OF SALVAGE TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: SULLIVAN KM FLOWERS MED NIMS J LEISENRING W SIADAK M WITHERSPOON R DEEG HJ SANDERS J ANASETTI C THOMPSON D APPELBAUM FR STORB R
Citation: Km. Sullivan et al., RESULTS OF 4 REGIMES OF SALVAGE TREATMENT OF REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 88(10), 1996, pp. 2564-2564
PREGNANCIES FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE WITH OR WITHOUT HIGH-DOSE BUSULFAN OR TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION
Authors: SANDERS JE HAWLEY J LEVY W GOOLEY T BUCKNER CD DEEG HJ DONEY K STORB R SULLIVAN K WITHERSPOON R APPELBAUM FR
Citation: Je. Sanders et al., PREGNANCIES FOLLOWING HIGH-DOSE CYCLOPHOSPHAMIDE WITH OR WITHOUT HIGH-DOSE BUSULFAN OR TOTAL-BODY IRRADIATION AND BONE-MARROW TRANSPLANTATION, Blood, 87(7), 1996, pp. 3045-3052
FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS
Authors: BENSINGER W APPELBAUM F ROWLEY S STORB R SANDERS J LILLEBY K GOOLEY T DEMIRER T SCHIFFMAN K WEAVER C CLIFT R CHAUNCEY T KLARNET J MONTGOMERY P PETERSDORF S WEIDEN P WITHERSPOON R BUCKNER CD
Citation: W. Bensinger et al., FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 13(10), 1995, pp. 2547-2555
CATARACTS AFTER BONE-MARROW TRANSPLANTATION - LONG-TERM FOLLOW-UP OF ADULTS TREATED WITH FRACTIONATED TOTAL-BODY IRRADIATION
Authors: BENYUNES MC SULLIVAN KM DEEG HJ MORI M MEYER W FISHER L BENSINGER R JACK MK HICKS J WITHERSPOON R BUCKNER CD HANSEN JA APPELBAUM FR STORB R
Citation: Mc. Benyunes et al., CATARACTS AFTER BONE-MARROW TRANSPLANTATION - LONG-TERM FOLLOW-UP OF ADULTS TREATED WITH FRACTIONATED TOTAL-BODY IRRADIATION, International journal of radiation oncology, biology, physics, 32(3), 1995, pp. 661-670
ALLOGENEIC MARROW GRAFTS FROM DONORS WITH CONGENITAL CHROMOSOMAL-ABNORMALITIES IN MARROW-CELLS
Authors: BARQUINERO J WITHERSPOON R SANDERS J HOROWITZ MM MONTUORO A PATTON DF BACIGALUPO A ABECASIS MM MIALE T ROZMAN C BRYANT E STORB R
Citation: J. Barquinero et al., ALLOGENEIC MARROW GRAFTS FROM DONORS WITH CONGENITAL CHROMOSOMAL-ABNORMALITIES IN MARROW-CELLS, British Journal of Haematology, 90(3), 1995, pp. 595-601
TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTERSTUDY
Authors: NASH RA ETZIONI R STORB R FURLONG T GOOLEY T ANASETTI C APPELBAUM FR DONEY K MARTIN P SLATTERY J SULLIVAN K VANDERJAGT R WITHERSPOON R JUSKO WJ ZAGER RA DEEG HJ
Citation: Ra. Nash et al., TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTERSTUDY, Blood, 85(12), 1995, pp. 3746-3753
HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT-LYMPHOMA
Authors: WEAVER CH PETERSEN FB APPELBAUM FR BENSINGER WI PRESS O MARTIN P SANDMAIER B DEEG HJ HANSEN JA BRUNVAND M ROWLEY S BENYUNES K CHAUNCEY T FEFER A HACKMAN R GOOLEY T SCHIFFMAN K STORB R SULLIVAN KM WEIDEN P WITHERSPOON R BUCKNER CD
Citation: Ch. Weaver et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT-LYMPHOMA, Journal of clinical oncology, 12(12), 1994, pp. 2559-2566
IDENTIFICATION OF GENE-SEQUENCES DIFFERENTIALLY EXPRESSED BETWEEN CD34-MARROW(38(LO) AND CD34+38(HI) CELLS ISOLATED FROM NORMAL HUMAN BONE)
Authors: GRAF L TOROKSTORB B WITHERSPOON R
Citation: L. Graf et al., IDENTIFICATION OF GENE-SEQUENCES DIFFERENTIALLY EXPRESSED BETWEEN CD34-MARROW(38(LO) AND CD34+38(HI) CELLS ISOLATED FROM NORMAL HUMAN BONE), Experimental hematology, 22(8), 1994, pp. 768-768
FUNCTIONAL DISSECTION OF THE HEMATOPOIETIC MICROENVIRONMENT WITH IMMORTALIZED HUMAN STROMAL CELL-LINES
Authors: ROECKLEIN BA TOROKSTORB B WITHERSPOON R
Citation: Ba. Roecklein et al., FUNCTIONAL DISSECTION OF THE HEMATOPOIETIC MICROENVIRONMENT WITH IMMORTALIZED HUMAN STROMAL CELL-LINES, Experimental hematology, 22(8), 1994, pp. 769-769
EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA
Authors: WEAVER CH CLIFT RA DEEG HJ STORB R APPELBAUM FR BENSINGER W DONEY K HANSEN JA MARTIN PO SANDERS J SULLIVAN KM THOMAS ED SINGER J WITHERSPOON R BUCKNER CD
Citation: Ch. Weaver et al., EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 14(6), 1994, pp. 885-893
FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS
Authors: NASH RA MCSWEENEY PA STORB R GOOLEY T FURLONG T APPELBAUM F DEEG HJ DONEY K MARTIN P SULLIVAN K WITHERSPOON R ZAGER RA HANSEN JA ANASETTI C
Citation: Ra. Nash et al., FK506 IN COMBINATION WITH METHOTREXATE (MTX) FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM PHENOTYPICALLY HLA-IDENTICAL UNRELATED DONORS, Blood, 84(10), 1994, pp. 10000394-10000394
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/
Authors: STORB R LEISENRING W DEEG HJ ANASETTI C APPELBAUM F BENSINGER W BUCKNER CD CLIFT R DONEY K HANSEN J MARTIN P SANDERS J STEWART P SULLIVAN K THOMAS ED WITHERSPOON R
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF GRAFT-VERSUS-HOST DISEASE PREVENTION BY METHOTREXATE CYCLOSPORINE VERSUS METHOTREXATE ALONE INPATIENTS GIVEN MARROW GRAFTS FOR SEVERE APLASTIC-ANEMIA/, Blood, 83(9), 1994, pp. 2749-2750
HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAVE RECEIVED DOSE-LIMITING RADIATION-THERAPY
Authors: WEAVER CH APPELBAUM FR PETERSEN FB CLIFT R SINGER J PRESS O BENSINGER W BIANCO J MARTIN P ANASETTI C BADGER C DEEG J DONY K HANSEN JA PETERSDORF E ROWLEY S STORB R SULLIVAN K WITHERSPOON R WEIDEN P BUCKNER CD
Citation: Ch. Weaver et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAVE RECEIVED DOSE-LIMITING RADIATION-THERAPY, Journal of clinical oncology, 11(7), 1993, pp. 1329-1335
AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION
Authors: PETERSEN FB LYNCH MHE CLIFT RA APPELBAUM FR SANDERS JE BENSINGER WI BENYUNES MC DONEY K FEFER A MARTIN P STORB R ROWLEY S SULLIVAN KM WITHERSPOON R WEIDEN P THOMAS ED FISHER L HANSEN JA BUCKNER CD
Citation: Fb. Petersen et al., AUTOLOGOUS MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED 1ST RELAPSE OR IN 2ND COMPLETE REMISSION, Journal of clinical oncology, 11(7), 1993, pp. 1353-1360
PREGNANCY OUTCOME AFTER MARROW TRANSPLANT FOR APLASTIC-ANEMIA OR HEMATOLOGIC MALIGNANCIES
Authors: SANDERS JE BUCKNER CD STORB R DONEY K SULLIVAN K WITHERSPOON R
Citation: Je. Sanders et al., PREGNANCY OUTCOME AFTER MARROW TRANSPLANT FOR APLASTIC-ANEMIA OR HEMATOLOGIC MALIGNANCIES, Experimental hematology, 21(8), 1993, pp. 1067-1067
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: DONEY K BUCKNER CD FISHER L PETERSEN FB SANDERS J APPELBAUM FR ANASETTI C BADGER C BENSINGER W DEEG HJ FEFER A MARTIN P PETERSDORF E SCHUENING F SINGER J STEWART P STORB R SULLIVAN KM WITHERSPOON R HANSEN JA
Citation: K. Doney et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC-LEUKEMIA, Bone marrow transplantation, 12(4), 1993, pp. 315-321
COMPARISON OF CYCLOSPORINE (CSP), PREDNISONE (PRED) OR ALTERNATING-DAY CSP PRED IN PATIENTS WITH STANDARD AND HIGH-RISK CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)/
Authors: SULLIVAN KM GOOLEY T NIMS J FLOWERS M LIN D ANASETTI C SANDERS J WITHERSPOON R APPELBAUM FR STORB R
Citation: Km. Sullivan et al., COMPARISON OF CYCLOSPORINE (CSP), PREDNISONE (PRED) OR ALTERNATING-DAY CSP PRED IN PATIENTS WITH STANDARD AND HIGH-RISK CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)/, Blood, 82(10), 1993, pp. 10000215-10000215
FK506 ALONE OR IN COMBINATION WITH METHOTREXATE (MTX) OR METHYLPREDNISOLONE (MP) FOR THE PREVENTION OF GRAFT-VS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTER STUDY
Authors: NASH RA DEEG HJ STORB R ETZIONI R FURLONG T GOOLEY T ANASETTI C APPELBAUM F DONEY K MARTIN P SULLIVAN K WITHERSPOON R ZAGER RA
Citation: Ra. Nash et al., FK506 ALONE OR IN COMBINATION WITH METHOTREXATE (MTX) OR METHYLPREDNISOLONE (MP) FOR THE PREVENTION OF GRAFT-VS-HOST DISEASE (GVHD) AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTER STUDY, Blood, 82(10), 1993, pp. 10000421-10000421
Risultati: 1-21 |